Oruka Therapeutics Inc (NASDAQ: ORKA) kicked off on Monday, down -4.92% from the previous trading day, before settling in for the closing price of $28.27. Over the past 52 weeks, ORKA has traded in a range of $5.49-$32.64.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 36.88%. While this was happening, its average annual earnings per share was recorded 43.49%. With a float of $42.67 million, this company’s outstanding shares have now reached $48.38 million.
Oruka Therapeutics Inc (ORKA) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Oruka Therapeutics Inc is 11.86%, while institutional ownership is 85.63%. The most recent insider transaction that took place on Jan 02 ’26, was worth 370,795. In this transaction Chief Operating Officer of this company sold 13,000 shares at a rate of $28.52, taking the stock ownership to the 205,084 shares. Before that another transaction happened on Jan 02 ’26, when Company’s Officer proposed sale 18,000 for $30.31, making the entire transaction worth $545,580.
Oruka Therapeutics Inc (ORKA) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.49 earnings per share (EPS), higher than consensus estimate (set at -0.98) by 0.49. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.79% during the next five years compared to 36.88% growth over the previous five years of trading.
Oruka Therapeutics Inc (NASDAQ: ORKA) Trading Performance Indicators
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.42, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -2.56 in one year’s time.
Technical Analysis of Oruka Therapeutics Inc (ORKA)
The latest stats from [Oruka Therapeutics Inc, ORKA] show that its last 5-days average volume of 0.63 million was inferior to 0.68 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 29.46%.
During the past 100 days, Oruka Therapeutics Inc’s (ORKA) raw stochastic average was set at 69.05%, which indicates a significant increase from 22.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.21 in the past 14 days, which was higher than the 1.73 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.01, while its 200-day Moving Average is $17.64. Now, the first resistance to watch is $28.21. This is followed by the second major resistance level at $29.54. The third major resistance level sits at $31.03. If the price goes on to break the first support level at $25.39, it is likely to go to the next support level at $23.90. The third support level lies at $22.57 if the price breaches the second support level.
Oruka Therapeutics Inc (NASDAQ: ORKA) Key Stats
The company with the Market Capitalisation of 1.30 billion has total of 48,409K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -83,720 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -30,280 K.
